最新的帖子

三月 12, 2012

Managing Total Cost of Ownership in a Changing Market

In 2012, the pharmaceutical industry will face many challenges, not the least of which will be the need to adjust research and development and business models to respond to the growing importance of specialty pharmaceuticals. Such products include sensitive biopharmaceuticals and the growth of biosimilars. Efficiency in manufacturing and the ability to meet critical compliance standards are a must to compete and meet today’s challenges. 
West Author Logo

Fran DeGrazio

VP, Scientific Affairs & Technical Services

Categories

Search the Blog

Archive